BamSEC and AlphaSense Join Forces
Learn More

Aura Biosciences Inc.

NASDAQ: AURA    
Share price (3/25/25): $7.08    
Market cap (3/25/25): $354 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 40 pages Aura Biosciences, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 39 pages Aura Biosciences, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.1
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 40 pages Aura Biosciences, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 39 pages Aura Biosciences, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.1
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 81 pages Aura Biosciences, Inc. Fifth Amended and Restated Investors’ Rights Agreement March 18, 2021
12/34/56
EX-4.2
from DRS 81 pages Aura Biosciences, Inc. Fifth Amended and Restated Investors’ Rights Agreement March 18, 2021
12/34/56